Characteristics of patients initiating empagliflozin or other noninsulin glucose lowering drugs (GLDs) in the United Kingdom (UK)

Category Primary study
JournalDiabetes
Year 2017
This article has no abstract
Epistemonikos ID: 49767af5c8a4bdb11a41825420773214685dc3e9
First added on: Feb 08, 2025